Evidence map›Paper›PMID 41993684›Full record

ArticleKidney medicine2026

ANCA-Negative Pauci-Immune Necrotizing Glomerulonephritis in the Setting of Multisystem Inflammatory Syndrome in Children.

Christine A VanBeek, Naseem Alammar, Qassim Abid

Abstract readCase Reports
In one paragraph

Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christine A VanBeekAmeripath Laboratories, Oklahoma City, OK.
Naseem AlammarDepartment of Pediatrics, Children's Hospital at University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Qassim AbidDepartment of Nephrology, Children's Hospital at University of Oklahoma Health Sciences Center, Oklahoma City, OK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a rare hyperinflammatory disorder that occurs in previously healthy pediatric patients after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure or mild infection. MIS-C typically has mild kidney symptoms that resolve quickly. The kidney biopsy experience in pediatric coronavirus disease 2019 (COVID-19) and MIS-C is limited in the literature. Here, we describe a 17-year-old SARS-CoV-2 positive boy with features of MIS-C who presented with abdominal pain and gross hematuria. He developed acute kidney injury requiring dialysis. Kidney biopsy and serologic work-up documented antineutrophil cytoplasmic antibody (ANCA)-negative pauci-immune necrotizing glomerulonephritis (AN-PING). Treatment with steroids and intravenous immunoglobulin resulted in simultaneous resolution of the systemic inflammatory markers and kidney symptoms. Aggressive immune suppression and cytotoxic agents were avoided. The glomerulonephritis remained in remission at 3-year follow-up. Although most cases of AN-PING are thought to represent kidney involvement by a primary vasculitis, a subset can occur in association with other conditions. We propose that AN-PING could be a rare kidney manifestation of MIS-C.

Indexed as

ANCA-negative pauci-immune necrotizing glomerulonephritiscrescentic glomerulonephritisgross hematuriamultisystem inflammatory syndrome in children (MIS-C)pediatric COVID-19

Identifiers

PMID41993684
PMCPMC13080582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.